Mitochondrial oxidant signalling in Alzheimer's disease

被引:0
|
作者
Vina, Jose [1 ]
Lloret, Ana [1 ]
Valles, Soraya L. [1 ]
Borras, Consuelo [1 ]
Badia, Mari-Carmen [1 ]
Pallardo, Federico V. [1 ]
Sastre, Juan [1 ]
Alonso, Maria-Dolores [1 ]
机构
[1] Fac Med, Dept Fisiol, Valencia 46010, Spain
关键词
apoptosis; gender; estrogenic compounds; antioxidants; MAP kinases;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The role of free radicals in Alzheimer disease pathophysiology has been appreciated for a long time. Originally, radicals were considered as causative of oxidative damage. More recently their role as signalling molecules in this, as well as in other fields of free radical biology, has been underscored. Mitochondria are both generators and targets of radical damage in aging. In this paper we review evidence that radicals generated in mitochondria in the presence of A beta are signals that trigger both the mitochondrial and the extra-mitochondrial pathways of apoptosis. There are gender specific differences in mitochondrial A beta toxicity: mitochondria from young (but not from old) females appear to be protected. 17-beta Estradiol or phytoestrogens like genistein prevent the formation of oxidants by mitochondria and protect against mitochondrial A beta toxicity. Experiments reported here indicate that phytoestrogens might have a role in the prevention of Alzheimer's disease.
引用
收藏
页码:175 / 181
页数:7
相关论文
共 50 条
  • [21] Mitochondrial function and Alzheimer's disease
    Ojaimi, J
    Byrne, E
    BIOLOGICAL SIGNALS AND RECEPTORS, 2001, 10 (3-4): : 254 - 262
  • [22] Is Alzheimer's disease a mitochondrial disorder?
    Cash, AD
    Perry, G
    Ogawa, O
    Raina, AK
    Zhu, XW
    Smith, MA
    NEUROSCIENTIST, 2002, 8 (05): : 489 - 496
  • [23] Mitochondrial dysfunction and Alzheimer's disease
    Maruszak, Aleksandra
    Zekanowski, Cezary
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2011, 35 (02): : 320 - 330
  • [24] Mitochondrial dysfunction and Alzheimer's disease
    Ghosh, SS
    Miller, S
    Herrnstadt, C
    Fahy, E
    Shinobu, LA
    Galasko, D
    Thal, LJ
    Beal, MF
    Howell, N
    Parker, WD
    Davis, RE
    PROGRESS IN ALZHEIMER'S AND PARKINSON'S DISEASES, 1998, 49 : 59 - 66
  • [25] Mitochondrial Disorders in Alzheimer's Disease
    Sukhorukov, Vladimir S.
    Mudzhiri, Natalia M.
    Voronkova, Anastasia S.
    Baranich, Tatiana I.
    Glinkina, Valeria V.
    Illarioshkin, Sergey N.
    BIOCHEMISTRY-MOSCOW, 2021, 86 (06) : 667 - 679
  • [26] Mitochondrial β-amyloid in Alzheimer's disease
    Borger, Eva
    Aitken, Laura
    Muirhead, Kirsty E. A.
    Allen, Zoe E.
    Ainge, James A.
    Conway, Stuart J.
    Gunn-Moore, Frank J.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2011, 39 : 868 - 873
  • [27] Mitochondrial abnormalities in Alzheimer's disease
    Hirai, K
    Aliev, G
    Nunomura, A
    Fujioka, H
    Russell, RL
    Atwood, CS
    Johnson, AB
    Kress, Y
    Vinters, HV
    Tabaton, M
    Shimohama, S
    Cash, AD
    Siedlak, SL
    Harris, PLR
    Jones, PK
    Petersen, RB
    Perry, G
    Smith, MA
    JOURNAL OF NEUROSCIENCE, 2001, 21 (09): : 3017 - 3023
  • [28] Mitochondrial therapeutics in Alzheimer's disease and Parkinson's disease
    Jake G Hoekstra
    Kathleen S Montine
    Jing Zhang
    Thomas J Montine
    Alzheimer's Research & Therapy, 3
  • [29] Mitochondrial therapeutics in Alzheimer's disease and Parkinson's disease
    Hoekstra, Jake G.
    Montine, Kathleen S.
    Zhang, Jing
    Montine, Thomas J.
    ALZHEIMERS RESEARCH & THERAPY, 2011, 3 (03):
  • [30] Delta Secretase and BDNF Signalling in Alzheimer's Disease
    Unlu, Buse
    Ildiz, Sumeyra
    Ak, Duygu Gezen
    Dursun, Erdinc
    EXPERIMED, 2023, 13 (01): : 1 - 7